Browse the corpus

REFERENCES Callejas JL, Oliver J, Martín J, et al, "Anakinra in Mutation-Negative CINCA Syndrome," Clin Rheumatol , 2007, 26(4):576-7. [PubMed 16440135 ] Gartlehner G, Hansen RA, Jonas BL, et al, "Biologics for the Treatment of Juvenile Idiopathic Arthritis: A Systematic Review and Critical Analysis of the Evidence," Clin Rheumatol , 2008, 27(1):67-76. [PubMed 17570009 ] Gattorno M, Piccini A, Lasigliè D, et al, "The Pattern of Response to Anti-Interleukin-1 Treatment Distinguishes Two Subsets of Patients With Systemic-Onset Juvenile Idiopathic Arthritis," Arthritis Rheum , 2008, 58(5):1505-15. [PubMed 18438814 ] Goldbach-Mansky R, Dailey NJ, Canna SW, et al, "Neonatal-Onset Multisystem Inflammatory Disease Responsive to Interleukin-1Beta Inhibition," N Engl J Med , 2006, 355(6):581-92. [PubMed 16899778 ] Ilowite N, Porras O, Reiff A, et al, "Anakinra in the Treatment of Polyarticular-Course Juvenile Rheumatoid Arthritis: Safety and Preliminary Efficacy Results of a Randomized Multicenter Study," Clin Rheumatol , 2009, 28(2):129-37. [PubMed 18766426 ] Irigoyen P, Olson J, Horn C, et al, "Treatement of Systemic Onset Juvenile Idiopathic Arthritis With Anakinra," Ped Rheumatol Online J , 2006, 4(2):123-34 Kashiwagi Y, Kawashima H, Nishimata S, et al, "Extreme Efficiency of Anti-Interleukin 1 Agent (Anakinra) in a Japanese Case of CINCA Syndrome," Clin Rheumatol , 2008, 27(2):277-9. [PubMed 17891446 ] Lequerré T, Quartier P, Rosellini D, et al, "Interleukin-1 Receptor Antagonist (Anakinra) Treatment in Patients With Systemic-Onset Juvenile Idiopathic Arthritis or Adult Onset Still Disease: Preliminary Experience in France," Ann Rheum Dis , 2008, 67(3):302-8. [PubMed 17947302 ] Lovell DJ, Bowyer SL, and Solinger AM, "Interleukin-1 Blockade by Anakinra Improves Clinical Symptoms in Patients With Neonatal-Onset Multisystem Inflammatory Disease," Arthritis Rheum , 2005, 52(4):1283-6. [PubMed 15818707 ] Matsubayashi T, Sugiura H, Arai T, et al, "Anakinra Therapy for CINCA Syndrome With a Novel Mutation in Exon 4 of the CIAS1 Gene," Acta Paediatr , 2006, 95(2):246-9. [PubMed 16449034 ] Ohlsson V, Baildam E, Foster H, et al, "Anakinra Treatment for Systemic Onset Juvenile Idiopathic Arthritis (SOJIA)," Rheumatology (Oxford) , 2008, 47(4):555-6. [PubMed 18321945 ]

Matsubayashi T, Sugiura H, Arai T, et al, "Anakinra Therapy for CINCA Syndrome With a Novel Mutation in Exon 4 of the CIAS1 Gene," Acta Paediatr , 2006, 95(2):246-9. [PubMed 16449034 ] Ohlsson V, Baildam E, Foster H, et al, "Anakinra Treatment for Systemic Onset Juvenile Idiopathic Arthritis (SOJIA)," Rheumatology (Oxford) , 2008, 47(4):555-6. [PubMed 18321945 ] Pascual V, Allantaz F, Arce E, et al, "Role of Interleukin-1 (IL-1) in the Pathogenesis of Systemic Onset Juvenile Idiopathic Arthritis and Clinical Response to IL-1 Blockade," J Exp Med , 2005, 201(9):1479-86. [PubMed 15851489 ] Reiff A, "The Use of Anakinra in Juvenile Arthritis," Curr Rheumatol Rep , 2005, 7(6):434-40. [PubMed 16303102 ] Rigante D, Ansuini V, Caldarelli M, et al, "Hydrocephalus in CINCA Syndrome Treated With Anakinra," Childs Nerv Syst , 2006, 22(4):334-7. [PubMed 16525848 ] Yang BB, Baughman S, and Sullivan JT, "Pharmacokinetics of Anakinra in Subjects With Different Levels of Renal Function," Clin Pharmacol Ther , 2003, 74(1):85-94. [PubMed 12844139 ] Topic 13251 Version 34.0 © 2013 UpToDate, Inc. All rights reserved. | Subscription and License Agreement | Release: 21.4 - C21.36 Licensed to: Southeast Alabama Med Ctr | Support Tag: [1105-83.177.194.223-DD2D800F1C-S244013.14]